# Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

> **NCT06835803** · PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Glioblastoma (GBM)

## Interventions

- **RADIATION:** Dose-escalated radiation therapy
- **RADIATION:** Standard hypofractionated radiation

## Key facts

- **NCT ID:** NCT06835803
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-14
- **Primary completion:** 2028-03-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06835803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06835803, "Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06835803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*